Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea
Public ClinicalTrials.gov record NCT03263273. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of 1% and 3% Topical MIinocycline Gel (HY01) in Patients With Papulopustular Rosacea
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the efficacy of once-daily application of 1% and 3% HY01 Topical Gel, as assessed by the change in inflammatory lesion count from baseline over the 12-week treatment period in patients with moderate-to-severe papulopustular rosacea.
Study identification
- NCT ID
- NCT03263273
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 270 participants
Conditions and interventions
Conditions
Interventions
- 1% Topical Minocycline Gel Drug
- 3% Topical Minocycline Gel Drug
- Topical Vehicle Gel Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 30, 2017 (Actual)
- Primary completion
- Mar 1, 2019 (Actual)
- Completion
- Jul 1, 2019 (Actual)
- Last update posted
- Nov 8, 2019
2017 – 2019
United States locations
- U.S. sites
- 23
- U.S. states
- 16
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Site - 15 | Bryant | Arkansas | 72022 | — |
| Clinical Site - 20 | Rogers | Arkansas | 72758 | — |
| Center for Dermatology Clinical Research, Inc. | Fremont | California | 94538 | — |
| Clinical Site - 19 | Santa Monica | California | 90404 | — |
| Clinical Site - 5 | Tampa | Florida | 33624 | — |
| Clinical Site - 16 | Boise | Idaho | 83704 | — |
| Clinical Site - 22 | Boston | Massachusetts | 02116 | — |
| Clinical Site - 23 | Watertown | Massachusetts | 02472 | — |
| Clinical Site - 14 | Clinton Township | Michigan | 48038 | — |
| Clinical Site - 6 | Fridley | Minnesota | 55432 | — |
| Clinical Site - 12 | Omaha | Nebraska | 68144 | — |
| Clinical Site - 21 | Berlin | New Jersey | 08009 | — |
| Clinical Site - 13 | New York | New York | 10022 | — |
| Clinical Site - 2 | New York | New York | 10155 | — |
| Clinical Site - 4 | High Point | North Carolina | 27262 | — |
| Clinical Site - 17 | Portland | Oregon | 97210 | — |
| Clinical Site - 11 | Fort Washington | Pennsylvania | 19034 | — |
| Clinical Site - 8 | Goodlettsville | Tennessee | 37072 | — |
| Clinical Site - 7 | Pflugerville | Texas | 78660 | — |
| Clinical Site - 18 | San Antonio | Texas | 78213 | — |
| Clinical Site - 3 | San Antonio | Texas | 78229 | — |
| Clinical Site - 9 | San Antonio | Texas | 78229 | — |
| Clinical Site - 10 | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03263273, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 8, 2019 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03263273 live on ClinicalTrials.gov.